CClinicalTrials.gg
CompletedNCT02349464PLEASEUpdated Jun 13, 2018

Promoting Lactation Education, Access, and Support Efforts for Preterm Infants

An interventional study of Specialized Preterm Infant/Mother Dyad Lactation Support in Breastfeeding, sponsored by Medical University of South Carolina. Completed. Per ClinicalTrials.gov, last updated 2018-06-13.

Sponsored by Medical University of South Carolina · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
70
Allocation
Randomized
Sex
All
01

Study summary

The purpose of this study is to determine whether a post-hospital discharge lactation support system increases preterm infant intake of mother's milk.

Read the detailed description

Preterm infants have barriers to successful breastfeeding that include oral feeding immaturity and high nutritional needs. Therefore, successful preterm infant breastfeeding requires increased counseling and equipment support compared to full-term infant breastfeeding. Inpatient preterm infant care has responded to these barriers, with specialized preterm infant lactation support. Unfortunately, for preterm infants, the onset of feeding maturity often coincides with hospital discharge and, therefore, inpatient, specialized lactation support ends just as the infant initiates nutritive feeding at the breast. Therefore, the success of preterm infant breastfeeding relies on the home environment and the community pediatric caregivers. A program has been created to provide this specialized preterm infant/mother outpatient lactation support. The program includes in-home availability of a hospital-grade electric pump and an infant weigh scale and pediatric clinic-based lactation counseling support. Fourteen pediatric practices are included in this study. Seven practices were randomized to intervention and seven were randomized to be controls.

02

Conditions studied

  • Breastfeeding
03

In context

Lead sponsor

Medical University of South Carolina is the lead sponsor of 852 studies on the registry; 165 are open to participants now.

Of its 128 completed or terminated interventional studies of FDA-regulated products, 101 (79%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Any infant discharge to home from the Medical University of South Carolina neonatal services
  • Born \<35 weeks' gestation
  • Mother providing her milk and plans to continue providing her milk for at least 6 months
  • The infant's post-discharge pediatric clinic identified by mother as one involved in the study
  • The eligible twin will be the first twin discharged from the hospital or, if discharge occurs simultaneously, the infant identified in the hospital as "twin A" will be eligible.

Exclusion criteria

Exclusion Criteria:

  • Infants with major congenital anomalies
  • Infants with anomalies affecting oral intake
  • Infants receiving tube feeds at hospital discharge
  • Infants receiving parenteral nutrition at hospital discharge
  • Triplet or greater pregnancies
  • Twin of the one enrolled twin will not be eligible.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
70 participants (actual)

Study arms

  • Active comparator
    Intervention

    For infants receiving pediatric care at one of the seven intervention practices, mothers will receive the Specialized Preterm Infant/Mother Dyad Lactation Support which includes home equipment and pediatric clinic-lactation support to support lactation for four months post-hospital discharge.

    Other: Specialized Preterm Infant/Mother Dyad Lactation Support

  • No intervention
    Control

    For infants receiving pediatric care at one of the seven control practices, mothers will receive standard support.

Interventions

  • OtherSpecialized Preterm Infant/Mother Dyad Lactation Support

    Mother will receive home equipment and pediatric clinic lactation support.

06

What researchers measure

Primary outcomes

  1. Preterm infant intake of mother's milk post-hospital discharge measured by survey.

    Time frame: 4 months

Secondary outcomes

  1. Preterm infant breastfeeding post-hospital discharge measured by survey.

    Time frame: 4 months

  2. Sustaining preterm infant mother's milk intake post-hospital discharge measured by survey.

    Time frame: 6 months

  3. Preterm infant growth post-hospital discharge collected from pediatric clinic medical record.

    Time frame: 6 months

  4. Preterm infant re-hospitalization post-hospital discharge collected from pediatric clinic medical record.

    Time frame: 6 months

  5. Preterm infant respiratory illness events post-hospital discharge collected from pediatric clinic medical record.

    Time frame: 6 months

  6. Preterm infant gastrointestinal illness events post-hospital discharge collected from pediatric clinic medical record.

    Time frame: 6 months

07

Study locations

No study locations are listed for this record.

08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jun 13, 2018, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT02349464
Lead sponsor
Medical University of South Carolina
Responsible party
Sponsor
First posted
Jan 29, 2015
Start date
Dec 2014
Primary completion
Feb 2018
Completion
Apr 2018
Last update
Jun 13, 2018

Study contacts

Sarah N Taylor, MD, MSCR
principal investigator · Medical University of South Carolina

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jun 2018. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion